X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-11 | WBA | Bhandari Inderpal S | Dir | P - Purchase | $18.05 | +3,000 | 3,000 | New | +$54,150 | ||||||
2024-04-02 | WBA | Mahajan Manmohan | EVP, Global CFO | P - Purchase | $19.38 | +6,000 | 166,969 | +4% | +$116,280 | ||||||
2024-01-29 | WBA | Jarrett Valerie B | Dir | P - Purchase | $22.44 | +4,456 | 4,456 | New | +$99,993 | ||||||
2024-01-16 | WBA | Schlichting Nancy M | Dir | S - Sale | $23.05 | -15,209 | 0 | -100% | -$350,567 | ||||||
2024-01-05 | WBA | Wentworth Timothy C | CEO | P - Purchase | $24.22 | +10,000 | 585,122 | +2% | +$242,220 | ||||||
2023-11-10 | WBA | Gates Richard P. | SVP, Chief Pharmacy Officer | S - Sale | $20.45 | -1,000 | 73,929 | -1% | -$20,450 | ||||||
2023-06-30 | WBA | Driscoll John Patrick | EVP, Pres U.S. Healthcare | P - Purchase | $28.42 | +5,172 | 59,050 | +10% | +$146,984 | ||||||
2023-03-29 | WBA | Brewer Rosalind G | CEO | P - Purchase | $33.95 | +10,000 | 369,945 | +3% | +$339,510 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |